Form 8-K - Current report:
SEC Accession No. 0001104659-21-119390
Filing Date
2021-09-24
Accepted
2021-09-24 17:26:16
Documents
12
Period of Report
2021-09-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128419d1_8k.htm   iXBRL 8-K 44915
  Complete submission text file 0001104659-21-119390.txt   219414

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alt-20210923.xsd EX-101.SCH 3189
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20210923_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20210923_pre.xml EX-101.PRE 22714
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2128419d1_8k_htm.xml XML 3603
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 211278355
SIC: 2834 Pharmaceutical Preparations